期刊
WORLD JOURNAL OF CLINICAL ONCOLOGY
卷 5, 期 4, 页码 705-712出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.5306/wjco.v5.i4.705
关键词
Phytoestrogens; Breast cancer; Cell signalling; Cell cycle; Epigenomics
类别
Phytoestrogens have multiple actions within target cells, including the epigenome, which could be beneficial to the development and progression of breast cancer. In this brief review the action of phytoestrogens on oestrogen receptors, cell signalling pathways, regulation of the cell cycle, apoptosis, steroid synthesis and epigenetic events in relation to breast cancer are discussed. Phytoestrogens can bind weakly to oestrogen receptors (ERs) and some have a preferential affinity for ER beta which can inhibit the transcriptional growth-promoting activity of ER alpha. However only saturating doses of phytoestrogens, stimulating both ER alpha and beta, exert growth inhibitory effects. Such effects on growth may be through phytoestrogens inhibiting cell signalling pathways. Phytoestrogens have also been shown to inhibit cyclin D1 expression but increase the expression of cyclin-dependent kinase inhibitors (p21 and p27) and the tumour suppressor gene p53. Again these effects are only observed at high (> 10) mu mol/L doses of phytoestrogens. Finally the effects of phytoestrogens on breast cancer may be mediated by their ability to inhibit local oestrogen synthesis and induce epigenetic changes. There are, though, difficulties in reconciling epidemiological and experimental data due to the fact experimental doses, both in vivo and in vitro, far exceed the circulating concentrations of free unbound phytoestrogens measured in women on a high phytoestrogen diet or those taking phytoestrogen supplements. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据